{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:12:37Z","timestamp":1782029557073,"version":"3.54.5"},"reference-count":37,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mucopolysaccharidosis type I (MPS I) is a rare monogenic disease in which glycosaminoglycans\u2019 abnormal metabolism leads to the storage of heparan sulfate and dermatan sulfate in various tissues. It causes its damage and impairment. Patients with the severe form of MPS I usually do not live up to the age of ten. Currently, the therapy is based on multidisciplinary care and enzyme replacement therapy or hematopoietic stem cell transplantation. Applying gene therapy might benefit the MPS I patients because it overcomes the typical limitations of standard treatments. Nanoparticles, including nanoemulsions, are used more and more in medicine to deliver a particular drug to the target cells. It allows for creating a specific, efficient therapy method in MPS I and other lysosomal storage disorders. This article briefly presents the basics of nanoemulsions and discusses the current state of knowledge about their usage in mucopolysaccharidosis type I.<\/jats:p>","DOI":"10.3390\/ijms23094785","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T11:45:55Z","timestamp":1650973555000},"page":"4785","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nanoemulsions as Gene Delivery in Mucopolysaccharidosis Type I\u2014A Mini-Review"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9935-472X","authenticated-orcid":false,"given":"Pawe\u0142","family":"Zapolnik","sequence":"first","affiliation":[{"name":"College of Medical Sciences, University of Rzesz\u00f3w, 35-959 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Pyrkosz","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, College of Medical Sciences, University of Rzesz\u00f3w, 35-959 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"ref_1","unstructured":"Orpha.net (2021, November 04). Mucopolysaccharidosis Type 1. Available online: https:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?Lng=GB&Expert=579."},{"key":"ref_2","unstructured":"(2021, November 04). Online Mendelian Inheritance in Man. Available online: https:\/\/www.omim.org\/entry\/607014."},{"key":"ref_3","unstructured":"(2021, December 09). MedlinePlus, Available online: https:\/\/medlineplus.gov\/genetics\/condition\/mucopolysaccharidosis-type-i\/#frequency."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1096-7192(02)00200-7","article-title":"Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients","volume":"78","author":"Matte","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"ref_5","unstructured":"Jones, K.L., Jones, M.C., and Del Campo, M. (2018). Atlas Malformacji Rozwojowych Wed\u0142ug Smitha, MediPage."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF02222956","article-title":"\u00dcber einen Typ multipler Abartungen, vorwiegend am Skelettsystem","volume":"24","author":"Hurler","year":"1920","journal-title":"Z. Kinder-Heilk."},{"key":"ref_7","first-page":"753","article-title":"A newly recognized forme fruste of Hurler\u2019s disease (gargoylism)","volume":"53","author":"Scheie","year":"1962","journal-title":"Am. J. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1542\/peds.57.1.111","article-title":"The iduronidase-deficient mucopolysaccharidoses: Clinical and roentgenorgraphic features","volume":"57","author":"Stevenson","year":"1976","journal-title":"Pediatrics"},{"key":"ref_9","unstructured":"(2021, November 09). Online Mendelian Inheritance in Man. Available online: https:\/\/www.omim.org\/clinicalSynopsis\/table?mimNumber=253010,601492,607016,607015,607014,253200,253220,252930,253000,252920,252900,309900."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1590\/S1415-47572012000600006","article-title":"Mucopolysacccharidoses: From understanding to treatment, a century of discoveries","volume":"35","author":"Giugliani","year":"2012","journal-title":"Genet. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.162.3853.570","article-title":"Hurler and Hunter syndromes: Mutual correction of the defect in cultured fibroblasts","volume":"162","author":"Fratantoni","year":"1968","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1016\/S0021-9258(19)85586-2","article-title":"Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues","volume":"255","author":"Hasilik","year":"1980","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10545-014-9718-3","article-title":"Treatment of lysosomal storage disorders: Successes and challenges","volume":"37","author":"Hollak","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/emmm.201202287","article-title":"Gene therapy on the move","volume":"5","author":"Kaufmann","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zapolnik, P., and Pyrkosz, A. (2021). Gene Therapy for Mucopolysaccharidosis Type II-A Review of the Current Possibilities. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115490"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejpb.2017.10.017","article-title":"Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR\/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers","volume":"122","author":"Schuh","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.colsurfb.2010.05.026","article-title":"Cationic nanoemulsions as non-viral vectors for plasmid DNA delivery","volume":"79","author":"Liu","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0169-409X(96)00467-X","article-title":"Emulsion formulations as a vector for gene delivery in vitro and in vivo","volume":"24","author":"Hara","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: Concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fnins.2020.00494","article-title":"Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs","volume":"14","author":"Naqvi","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.2174\/1381612821666150531164540","article-title":"Lipid-Based Nanocarriers for RNA Delivery","volume":"21","author":"Xue","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s13346-013-0133-3","article-title":"Nanotechnology for CNS delivery of bio-therapeutic agents","volume":"3","author":"Shah","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.colsurfb.2015.07.056","article-title":"Nanoemulsion-templated polylelectrolyte multifunctional nanocapsules for DNA entrapment and bioimaging","volume":"137","author":"Saczko","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/mt.2014.133","article-title":"A cationic nanoemulsion for the delivery of next-generation RNA vaccines","volume":"22","author":"Brito","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s12272-009-1500-y","article-title":"Lipid-based emulsion system as non-viral gene carriers","volume":"32","author":"Nam","year":"2009","journal-title":"Arch. Pharm. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijpharm.2017.10.030","article-title":"Cationic nanoemulsions as nucleic acids delivery systems","volume":"534","author":"Teixeira","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2015.04.013","article-title":"PEGylated cationic nanoemulsions can efficiently bind and transfect pIDUA in a mucopolysaccharidosis type I murine model","volume":"209","author":"Fraga","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2147\/IJN.S121558","article-title":"Factors influencing transfection efficiency of pIDUA\/nanoemulsion complexes in a mucopolysaccharidosis type I murine model","volume":"12","author":"Fraga","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2174\/1566523221666210126151420","article-title":"Gene Therapy of Mucopolysaccharidosis Type I Mice: Repeated Administrations and Safety Assessment of pIDUA\/Nanoemulsion Complexes","volume":"21","author":"Fraga","year":"2021","journal-title":"Curr. Gene Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2018.06.049","article-title":"Intra-articular nonviral gene therapy in mucopolysaccharidosis I mice","volume":"548","author":"Bidone","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11095-018-2503-5","article-title":"Nasal Administration of Cationic Nanoemulsions as Nucleic Acids Delivery Systems Aiming at Mucopolysaccharidosis Type I Gene Therapy","volume":"35","author":"Schuh","year":"2018","journal-title":"Pharm. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: Implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Poletto, E., Baldo, G., and Gomez-Ospina, N. (2020). Genome Editing for Mucopolysaccharidoses. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020500"},{"key":"ref_36","unstructured":"(2021, December 01). ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/results?cond=Mucopolysaccharidosis+I+gene+therapy&term=&cntry=&state=&city=&dist=."},{"key":"ref_37","unstructured":"(2021, December 01). ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/results?cond=nanoemulsion&term=&cntry=&state=&city=&dist=."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/9\/4785\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:01:34Z","timestamp":1760137294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/9\/4785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["ijms23094785"],"URL":"https:\/\/doi.org\/10.3390\/ijms23094785","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]}}}